You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 7,416,874


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,416,874
Title:Recombinant bacterial phytases and uses thereof
Abstract: A purified recombinant phytase enzyme derived from Escherichia coli B. The enzyme has a molecular weight of about 47.1 kilodaltons and has phytase activity. The enzyme can be produced from native or recombinant host cells and can be used to aid in the digestion of phytate where desired. In particular, the phytase of the present invention can be used in foodstuffs to improve the feeding value of phytate rich ingredients.
Inventor(s): Short; Jay M. (Del Mar, CA)
Assignee: Verenium Corporation (San Diego, CA)
Application Number:10/430,356
Patent Claims:1. An isolated, synthetic or recombinant nucleic acid encoding a polypeptide having phytase activity that is expressed and secreted in a yeast cell, wherein the nucleic acid is generated by a method comprising the following steps: (a) providing a nucleic acid comprising (i) the sequence of SEQ ID NO: 1, (ii) the sequence of SEQ ID NO: 1, wherein T can also be U, (iii) the sequence of a nucleic acid encoding a polypeptide comprising the sequence of SEQ ID NO: 2, (iv) the sequence of a nucleic acid encoding a polypeptide having the amino acid sequence of SEQ ID NO: 2 from amino acid residues 1 to 432, (v) the sequence of a nucleic acid encoding a polypeptide having the amino acid sequence of SEQ ID NO: 2 from amino acid residue 1 to 432 and a heterologous amino acid sequence; (vi) the sequence of SEQ ID NO: 1 from nucleotide residue 1 to 1296, or (vii) sequences completely complementary to (i), (ii), (iii), (iv), (v), or (vi); (b) modifying one or more nucleotides in the nucleic acid to another nucleotide, deleting one or more nucleotides in the nucleic acid, or adding one or more nucleotides to the nucleic acid, wherein the modified nucleic acid encodes a polypeptide having phytase activity and the modified nucleic acid hybridizes under stringent hybridization conditions to the nucleic acid of SEQ ID NO: 1, wherein the hybridization occurs because the modified nucleic acid has at least 95% sequence identity to SEQ ID NO: 1, and all the modifications result in a conservative amino acid substitution of one amino acid for another amino acid; and (c) adding to the nucleic acid of (b) a nucleic acid encoding a yeast secretory signal peptide or transit peptide; wherein expressing the nucleic acid in a yeast cell generates a secreted polypeptide having phytase activity.

2. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by a method selected from the group consisting of error-prone PCR, shuffling, oligonucleotide-directed mutagenesis, assembly PCR, sexual PCR mutagenesis, in vivo mutagenesis, cassette mutagenesis, recursive ensemble mutagenesis, exponential ensemble mutagenesis, site-specific mutagenesis, ligation reassembly, Gene Site Saturation Mutagenesis (GSSM) and any combination thereof.

3. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by error-prone PCR.

4. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by shuffling.

5. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by oligonucleotide-directed mutagenesis.

6. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by assembly PCR.

7. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by sexual PCR mutagenesis.

8. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by in vivo mutagenesis.

9. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by cassette mutagenesis.

10. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by recursive ensemble mutagenesis.

11. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by exponential ensemble mutagenesis.

12. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by site-specific mutagenesis.

13. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modifications are introduced by Gene Site Saturation Mutagenesis (GSSM).

14. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the nucleic acid is a vector.

15. The isolated, synthetic or recombinant nucleic acid of claim 14, wherein the vector is an expression vector.

16. The isolated, synthetic or recombinant nucleic acid of claim 14, wherein the vector comprises or is a viral vector, a bacterial vector or a vector derived from a bacteria from the genus Agrobacterium.

17. The isolated, synthetic or recombinant nucleic acid of claim 14, wherein the vector comprises or is a Cauliflower Mosaic Virus (CaMV), a tobacco mosaic virus or a Ti plasmid.

18. The isolated, synthetic or recombinant nucleic acid of claim 14, wherein the vector comprises or is a plasmid, a viral vector, a mammalian expression vector, a phage, a phagemid, a cosmid, a fosmid, a bacterial artificial chromosome, a P1 based artificial chromosome, a yeast plasmid, a yeast artificial chromosome, a viral particle, a derivative of SV40 or a baculovirus.

19. The isolated, synthetic or recombinant nucleic acid of claim 1, further comprising a coding sequence for a label or a tag.

20. The isolated, synthetic or recombinant nucleic acid of claim 19, wherein the label or tag comprises a His tag or a green fluorescent protein tag.

21. The isolated, synthetic or recombinant nucleic acid of claim 1, further comprising a promoter or a transcriptional control sequence, wherein the nucleic acid is operatively linked to the promoter or the transcriptional control sequence.

22. The isolated, synthetic or recombinant nucleic acid of claim 21, wherein the promoter or the transcriptional control sequence is operable in a plant cell, a plant part or a plant.

23. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the nucleic acid further comprises an intron or a non-protein coding sequence positioned 5' or 3' to the sequence of the nucleic acid of claim 1.

24. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein in step (b) the modified nucleic acid encodes a polypeptide having a sequence as set forth in SEQ ID NO:2, or a truncated form of the phytase of SEQ ID NO:2, wherein the truncated form has the same phytase activity as that of the polypeptide of SEQ ID NO:2.

25. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the modified nucleic acid encodes a polypeptide having a phytase activity, and the modified nucleic acid hybridizes under stringent conditions to the nucleic acid of SEQ ID NO: 1, wherein the hybridization occurs because the modified nucleic acid has at least 97% sequence identity to SEQ ID NO: 1.

26. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein substitution of one amino acid for another amino acid comprises substitution of an isoleucine, valine, leucine, or methionine, for another isoleucine, valine, leucine, or methionine; or, substitution of an arginine for a lysine, a glutamic acid for an aspartic acid, or a glutamine for an asparagine.

27. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the nucleic acid further comprises (a) a non-coding sequence; (b) a sequence encoding an N-terminal identification peptide; (c) a sequence encoding a peptide imparting a desired characteristic; or (d) a sequence encoding a polypeptide for stabilization or simplified purification of an expressed recombinant product.

28. A synthetic nucleic acid having the sequence of the nucleic acid of claim 1.

29. The isolated, synthetic or recombinant nucleic acid of claim 1, further comprising adding to the nucleic acid of (c): a nucleic acid encoding a polypeptide for use in purifying the mature enzyme; or, a nucleic acid encoding a polypeptide for use as an N-terminal identification peptide.

30. The isolated, synthetic or recombinant nucleic acid of claim 1, further comprising a nucleic acid sequence encoding a polypeptide or peptide for stabilization or simplified purification of an expressed recombinant product.

31. The isolated, synthetic or recombinant nucleic acid of claim 1, wherein the heterologous amino acid sequence comprises a leader sequence capable of directing secretion of translated enzyme, or the sequence of an N-terminal identification peptide imparting stabilization or simplified purification of an expressed recombinant product.

32. An isolated cell comprising the nucleic acid of claim 1.

33. The isolated cell of claim 32, wherein the cell is a plant cell.

34. The isolated cell of claim 33, wherein the plant cell is a soybean or a corn cell.

35. The isolated cell of claim 32, wherein the cell is a bacterial cell, a yeast cell, a mammalian cell, a fungal cell, or an insect cell.

36. An isolated, synthetic or recombinant nucleic acid encoding a polypeptide having phytase activity generated by a method comprising the following steps: (a) providing a nucleic acid comprising (i) the sequence of SEQ ID NO: 1, (ii) the sequence of SEQ ID NO: 1, wherein T can also be U, (iii) the sequence of a nucleic acid encoding a polypeptide comprising the sequence of SEQ ID NO: 2, (iv) the sequence of a nucleic acid encoding a polypeptide having the amino acid sequence of SEQ ID NO: 2 from amino acid residues 1 to 432, (v) the sequence of a nucleic acid encoding a polypeptide having the amino acid sequence of SEQ ID NO: 2 from amino acid residue 1 to 432 and a heterologous amino acid sequence; (vi) the sequence of SEQ ID NO: 1 from nucleotide residue 1 to 1296, or (vii) sequences completely complementary to (i), (ii), (iii), (iv), (v), or (vi); (b) modifying one or more nucleotides in the nucleic acid to another nucleotide, deleting one or more nucleotides in the nucleic acid, or adding one or more nucleotides to the nucleic acid, wherein the modified nucleic acid encodes a polypeptide having phytase activity and the modified nucleic acid hybridizes under stringent hybridization conditions to the nucleic acid of SEQ ID NO: 1, wherein the hybridization occurs because the modified nucleic acid has at least 95% sequence identity to SEQ ID NO: 1, and all the modifications result in a conservative amino acid substitution of one amino acid for another amino acid; and (c) adding to the nucleic acid of (b) a nucleic acid encoding a heterologous secretory signal peptide or transit peptide; wherein expressing the nucleic acid produces a polypeptide having phytase activity.

37. The isolated, synthetic or recombinant nucleic acid of claim 36, wherein the modifications are introduced by a method selected from the group consisting of error-prone PCR, shuffling, oligonucleotide-directed mutagenesis, assembly PCR, sexual PCR mutagenesis, in vivo mutagenesis, cassette mutagenesis, recursive ensemble mutagenesis, exponential ensemble mutagenesis, site-specific mutagenesis, ligation reassembly, Gene Site Saturation Mutagenesis (GSSM) and any combination thereof.

38. The isolated, synthetic or recombinant nucleic acid of claim 36, wherein the modified nucleic acid encodes a polypeptide having a phytase activity, and the modified nucleic acid hybridizes under stringent conditions to the nucleic acid of SEQ ID NO: 1, wherein the hybridization occurs because the modified nucleic acid has at least 97% sequence identity to SEQ ID NO: 1.

39. The isolated, synthetic or recombinant nucleic acid of claim 36, further comprising a nucleic acid encoding a peptide or polypeptide for stabilization or simplified purification of an expressed recombinant product.

40. The isolated, synthetic, of recombinant nucleic acid of claim 36 wherein step (c) comprises adding to the nucleic acid of (b) a nucleic acid encoding a heterologous secretory signal peptide of microbial origin.

41. The isolated, synthetic or recombinant nucleic acid of claim 36, wherein the nucleic acid further comprises (a) a non-coding sequence, (b) a sequence encoding a leader or secretory peptide, (c) a sequence encoding a peptide for purification of the mature enzyme or proprotein, or (d) a sequence encoding an N-terminal identification peptide imparting a desired characteristic.

42. An isolated, synthetic or recombinant nucleic acid encoding a polypeptide having phytase activity that is expressed in a plant cell, wherein the nucleic acid is generated by a method comprising the following steps: (a) providing a nucleic acid comprising (i) the sequence of SEQ ID NO: 1, (ii) the sequence of SEQ ID NO: 1, wherein T can also be U, (iii) the sequence of a nucleic acid encoding a polypeptide comprising the sequence of SEQ ID NO: 2, (iv) the sequence of a nucleic acid encoding a polypeptide having the amino acid sequence of SEQ ID NO: 2 from amino acid residues 1 to 432, (v) the sequence of a nucleic acid encoding a polypeptide having the amino acid sequence of SEQ ID NO: 2 from amino acid residue 1 to 432 and a heterologous amino acid sequence; (vi) the sequence of SEQ ID NO: 1 from nucleotide residue 1 to 1296, or (vii) sequences completely complementary to (i), (ii), (iii), (iv), (v), or (vi); (b) modifying one or more nucleotides in the nucleic acid to another nucleotide, deleting one or more nucleotides in the nucleic acid, or adding one or more nucleotides to the nucleic acid, wherein the modified nucleic acid encodes a polypeptide having phytase activity and the modified nucleic acid hybridizes under stringent hybridization conditions to the nucleic acid of SEQ ID NO: 1, wherein the hybridization occurs because the modified nucleic acid has at least 95% sequence identity to SEQ ID NO: 1, and all the modifications result in a conservative amino acid substitution of one amino acid for another amino acid; and (c) adding to the nucleic acid of (b) a nucleic acid encoding a plant secretory signal peptide or transit peptide; wherein expressing the nucleic acid in a plant cell produces a polypeptide having phytase activity.

43. A synthetic nucleic acid having the sequence of the nucleic acid of claim 42.

44. The synthetic nucleic acid of claim 43, further comprising a nucleic acid encoding a peptide or polypeptide for stabilization or simplified purification.

45. The isolated, synthetic or recombinant nucleic acid of claim 42, wherein the nucleic acid further encodes a label or a tag.

46. The isolated, synthetic or recombinant nucleic acid of claim 45, wherein the tag or label comprises a 6.times.His tag, or a green fluorescent protein tag.

47. The isolated, synthetic or recombinant nucleic acid of claim 42, wherein the nucleic acid further comprises (a) a non-coding sequence, (b) a sequence encoding a leader or secretory peptide, (c) a sequence encoding a peptide for purification of the mature enzyme or proprotein, or (d) a sequence encoding an N-terminal identification peptide imparting a desired characteristic.

48. The isolated, synthetic or recombinant nucleic acid of claim 42, wherein the plant secretory signal peptide targets the polypeptide having phytase activity to a vacuole.

49. The isolated, synthetic or recombinant nucleic acid of claim 42, wherein in step (b) the modified nucleic acid encodes a polypeptide having a sequence as set forth in SEQ ID NO:2, or a truncated form of the phytase of SEQ ID NO:2, wherein the truncated form has the same phytase activity as that of the polypeptide of SEQ ID NO:2.

50. A method of generating a nucleic acid encoding a phytase variant comprising (i) providing a nucleic acid as set forth in claim 1 and, (ii) modifying one or more nucleotides in the nucleic acid to another nucleotide, deleting one or more nucleotides in the nucleic acid, or adding one or more nucleotides to the nucleic acid, thereby generating a nucleic acid encoding a phytase variant.

51. The method of claim 50, wherein the modifications are introduced by a method selected from the group consisting of error-prone PCR, shuffling, oligonucleotide-directed mutagenesis, assembly PCR, sexual PCR mutagenesis, in vivo mutagenesis, cassette mutagenesis, recursive ensemble mutagenesis, exponential ensemble mutagenesis, site-specific mutagenesis, ligation reassembly, gene site saturated mutagenesis (GSSM) and any combination thereof.

52. The method of claim 50, wherein the modifications are introduced by error-prone PCR.

53. The method of claim 50, wherein the modifications are introduced by shuffling.

54. The method of claim 50, wherein the modifications are introduced by oligonucleotide-directed mutagenesis.

55. The method of claim 50, wherein the modifications are introduced by assembly PCR.

56. The method of claim 50, wherein the modifications are introduced by sexual PCR mutagenesis.

57. The method of claim 50, wherein the modifications are introduced by in vivo mutagenesis.

58. The method of claim 50, wherein the modifications are introduced by cassette mutagenesis.

59. The method of claim 50, wherein the modifications are introduced by recursive ensemble mutagenesis.

60. The method of claim 50, wherein the modifications are introduced by exponential ensemble mutagenesis.

61. The method of claim 50, wherein the modifications are introduced by site-specific mutagenesis.

62. A method of introducing a phytase activity into a plant, plant part or plant cell comprising introducing a nucleic acid into the plant, plant part or plant cell by transformation of protoplasts, or introducing a vector into the plant, plant part, or plant cell, wherein the nucleic acid comprises the nucleic acid of claim 1.

63. The method of claim 62, wherein the nucleic acid is introduced into the plant, plant part or plant cell by a calcium/polyethylene glycol method, electroporation, microinjection or particle bombardment.

64. The method of claim 62, wherein the vector comprises or is a viral vector, a bacterial vector or a vector from the genus Agrobacterium.

65. The method of claim 64, wherein the viral vector comprises or is a Cauliflower Mosaic Virus (CaMV).

66. The method of claim 62, wherein the nucleic acid encodes a polypeptide having a sequence as set forth in SEQ ID NO:2.

67. A method of introducing a phytase activity into a plant, plant part or plant cell comprising introducing a nucleic acid into the plant, plant part or plant cell by transformation of protoplasts, or introducing a vector into the plant, plant part, or plant cell, wherein the nucleic acid comprises the nucleic acid of claim 36.

68. The method of claim 67, wherein the vector comprises or is a viral vector, a bacterial vector, a vector from the genus Agrobacterium, or a Cauliflower Mosaic Virus (CaMV).

Details for Patent 7,416,874

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2017-08-13
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2017-08-13
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2017-08-13
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.